Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions

• Christian Lienhardt ,

  * E-mail: lienhardtc@who.int

  Affiliation World Health Organisation, Geneva, Switzerland

  ⨯
• Knut Lönnroth,

  Affiliation World Health Organisation, Geneva, Switzerland

  ⨯
• Dick Menzies,

  Affiliation Montreal Chest Institute, McGill University, Montreal, Canada

  ⨯
• Manica Balasegaram,

  Affiliation Access Campaign, Médecins Sans Frontières, Geneva, Switzerland

  ⨯
• Jeremiah Chakaya,

  Affiliation Centre for Respiratory Diseases Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya

  ⨯
• Frank Cobelens,

  Affiliation Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands

  ⨯
• Jennifer Cohn,

  Affiliation Access Campaign, Médecins Sans Frontières, Geneva, Switzerland

  ⨯
• Claudia M. Denkinger,

  Affiliation FIND Diagnostics, Geneva, Switzerland

  ⨯
• Thomas G. Evans,

  Affiliation Aeras, Rockville, Maryland, United States of America

  ⨯
• Gunilla Källenius,

  Affiliation Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Gilla Kaplan,

  Affiliation Bill & Melinda Gates Foundation, Seattle, Washington, United States of America

  ⨯
• Ajay M. V. Kumar,

  Affiliation International Union Against Tuberculosis and Lung Disease, South-East Asia Regional Office, New Delhi, India

  ⨯
• Line Matthiessen,

  Affiliation DG Research & Innovation, European Commission, Brussels, Belgium

  ⨯
• Charles S. Mgone,

  Affiliation The European & Developing Countries Clinical Trials Partnership (EDCTP), The Hague, The Netherlands

  ⨯
• Valerie Mizrahi,

  Affiliation Institute of Infectious Disease & Molecular Medicine, University of Cape Town, Cape Town, South Africa

  ⨯
• Ya-diul Mukadi,

  Affiliation USAID, Washington, D.C., United States of America

  ⨯
• Viet Nhung Nguyen,

  Affiliation National TB Programme, National Lung Hospital, Hanoi, Viet Nam

  ⨯
• Anders Nordström,

  Affiliation Ambassador for Global Health, Ministry for Foreign Affairs, Stockholm, Sweden

  ⨯
• Christine F. Sizemore,

  Affiliation Tuberculosis, Leprosy and other Mycobacterial Diseases Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America

  ⨯
• Melvin Spigelman,

  Affiliation Global Alliance for TB Drug Development, New York, New York, United States of America

  ⨯
• S. Bertel Squire,

  Affiliation Centre for Applied Health Research & Delivery, Liverpool School of Tropical Medicine, Liverpool, United Kingdom

  ⨯
• Soumya Swaminathan,

  Affiliation National Institute for Research in Tuberculosis (NIRT), Indian Council of Medical Research, Chennai, India

  ⨯
• Paul D. Van Helden,

  Affiliation DST/NRF Centre of Excellence for Biomedical Tuberculosis Research, MRC Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa

  ⨯
• Alimuddin Zumla,

  Affiliation Division of Infection and Immunity, University College London Medical School, London, United Kingdom

  ⨯
• Karin Weyer,

  Affiliation World Health Organisation, Geneva, Switzerland

  ⨯
• Diana Weil,

  Affiliation World Health Organisation, Geneva, Switzerland

  ⨯
•  [ ... ],
• Mario Raviglione

  Affiliation World Health Organisation, Geneva, Switzerland

  ⨯
• [ view all ]
• [ view less ]